MPH Health Care AG
ISIN: DE000A289V03
WKN: A289V0
11 June 2024 08:30AM

EQS-News: MPH Health Care AG: Q1-results 2024

MPH Health Care AG · ISIN: DE000A289V03 · EQS - Company News
Country: Germany · Primary market: Germany · EQS NID: 1921963

EQS-News: MPH Health Care AG / Key word(s): Quarter Results/Quarterly / Interim Statement
MPH Health Care AG: Q1-results 2024

11.06.2024 / 08:30 CET/CEST
The issuer is solely responsible for the content of this announcement.


MPH Health Care AG: Q1-results 2024 

Strong increase in earnings due to positive development of investments. Equity (net asset value) increases significantly to EUR 251.6 million. This corresponds to EUR 58.77 per share (prior-year quarter Q1/2023: EUR 43.91). The equity ratio rises to 94.3%.

Berlin, 11 June 2024 - MPH Health Care AG (ISIN: DE000A289V03) announces the preliminary IFRS consolidated results for the first quarter of 2024. Accordingly, the net asset value (NAV) per share increased from EUR 43.91 at the same time last year to EUR 58.77 as of March 31, 2024. This corresponds to an increase of around 34%.   

Compared to 31 December 2023, equity increased slightly from EUR 251.0 million to EUR 251.6 million as of 31 March 2024. At 94.3% per end of March 2024, the equity ratio remained high and increased slightly (31.12.2023: 94,2%).

The operating result (EBIT) improved from EUR -33.93 million as of 31 March 2023 to EUR 0.71 million. The IFRS result for the period for the first quarter of 2024 rose to EUR 0.67 million (same quarter of the previous year: EUR -33.42 million).

MPH AG is an investment company whose investments are reported as financial assets under the balance sheet item “Financial assets” and are measured at fair value through profit or loss as at the balance sheet date. The profit for the period is mainly the result of the fair value measurement of the listed investments held as at the reporting date, which result from the higher market prices of the investments compared to the previous year's reporting date of 31.12.2023 and do not affect liquidity.

The investments M1 Kliniken AG and CR Energy AG, which are listed on the Frankfurt Stock Exchange, were very successful operationally in the first quarter of 2024.

M1 Kliniken AG increased consolidated Group sales to EUR 84.7 million in the first quarter of 2024 (previous year: EUR 76.8 million). In the Beauty segment, sales increased by more than 18% to EUR 24.7 million and the EBIT margin in this segment rose from 17.3% to 21.9%.

The M1 Group's consolidated EBIT improved disproportionately by 70% to EUR 6.8 million in Q1/2024 (previous year: EUR 4.0 million). The Group EBIT margin increased from 5.3% to 8.1%. 

The share price of M1 Kliniken AG increased from EUR 11.20 on 31 December 2023 to EUR 13.10 on 31 March 2024. At the end of May 2024, the share price was already at EUR 20.70.

CR Energy AG and its portfolio companies remain on a profitable course. According to the audited figures for the 2023 financial year, EBIT decreased from EUR 76.3 million to EUR 66.4 million. Equity increased sharply from 314.2 million euros to 393.5 million euros. The equity ratio is stable at over 97%, documenting the company's excellent equity financing.

CR Energy is increasingly involved in the renewable energy supply and sustainable living sectors, whose markets are worth billions.

At its Annual General Meeting to be held on 27 June 2024, the company intends to propose that an amount of EUR 17.64 million be transferred from retained earnings to other revenue reserves, thereby increasing the company's share capital from company funds by issuing bonus shares to the company's existing shareholders at a ratio of 1:3. The new shares are to carry dividend rights from 1 January 2024.

The CR Energy AG share price fell slightly from EUR 28.90 on 31 December 2023 to EUR 25.80 on 31 March 2024. At the end of May 2024, however, the share price was already back at EUR 28.50.

„Despite the ongoing conflict situation in Ukraine and the Middle East and the still high energy costs, we are confident about the development in 2024. The strong operating performance of M1 Kliniken AG should continue for the rest of the year. The focus is clearly on expanding the “M1 Med Beauty”-network of locations and further increasing shareholder value. With its vertically integrated investment portfolio, CR Energy AG is very well positioned in the areas of “sustainable energy supply concepts” and “quality and cost-optimized living space”. MPH can also systematically benefit from the positive developments of the investments in the coming years,” says Patrick Brenske, CEO of MPH.

About MPH Health Care AG:
MPH AG is an investment company with a strategic focus on the acquisition, development and sale of companies and company shares, particularly in growth segments of the healthcare market. This includes both insurance-financed and privately financed segments. However, MPH also exploits potential outside the healthcare market in high-growth and profitable sectors.


Contact:
Patrick Brenske, Management Board
Corporate Communications
E-Mail: ir@mph-ag.de


11.06.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: MPH Health Care AG
Grünauer Straße 5
12557 Berlin
Germany
Phone: 030 / 863 21 45 60
Fax: 030 / 863 21 45 69
E-mail: info@mph-ag.de
Internet: www.mph-ag.de
ISIN: DE000A289V03, DE000A289VT5
WKN: A289V0
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1921963

 
End of News EQS News Service

1921963  11.06.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1921963&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f

Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.

The most important financial data at a glance
  2018 2019 2020 2021 2022 2023 2024e
Sales1 39,53 41,22 3,43 13,55 30,67 34,46 0,00
EBITDA1,2 37,69 11,59 -70,99 -9,05 29,59 29,54 0,00
EBITDA-Margin3 95,35 28,12 -2.069,68 -66,79 96,48 85,72 0,00
EBIT1,4 37,64 11,58 -71,02 -9,07 29,56 30,21 0,00
EBIT-Margin5 95,22 28,09 -2.070,55 -66,94 96,38 87,67 0,00
Net Profit (Loss)1 37,02 11,08 -70,38 -8,96 29,11 29,54 0,00
Net-Margin6 93,65 26,88 -2.051,90 -66,13 94,91 85,72 0,00
Cashflow1,7 5,20 -1,35 -2,89 -1,09 0,00 -2,02 0,00
Earnings per share8 8,60 2,60 -16,44 -2,09 6,80 -2,80 1,10
Dividend per share8 2,00 0,00 0,00 0,00 0,00 1,20 1,20
Quelle: boersengefluester.de and Company information
Explanation

1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de

Auditor: Harry Haseloff

All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.

INVESTOR-INFORMATION
©boersengefluester.de
MPH Health Care
WKN ISIN Legal Type Marketcap IPO Recommendation Plus Code
A289V0 DE000A289V03 AG 96,76 Mio € 01.09.2009 Kaufen 9F4MCHV9+6R
* * *
PE 2025e PE 10Y-Ø BGFL-Ratio Shiller-PE PB PCF KUV
6,11 7,21 0,85 4,74 0,30 -48,00 2,81
Dividends
Dividend '2022
in €
Dividend '2023
in €
Dividend '2024e
in €
Div.-Yield '2024e
in %
0,00 1,20 1,20 5,31%
Financial calendar
Annual General Meeting Q1-figures Q2-figures Q3-figures Annual press conference
18.07.2024 11.06.2024 05.09.2024 21.11.2024 30.05.2024
Performance
Distance 60-days-line Distance 200-days-line Performance YtD Performance 52 weeks IPO
Last Price (EoD)
-1,74%
22,60 €
ATH 54,50 €
-6,73% -7,62% +35,74% +38,65% +0,00%

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
          Qualitätsjournalismus · Made in Germany © 2024          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2024 by Gereon Kruse #BGFL